Trial Profile
A Randomized , Open Label, Dose Titration Study to Evaluate the Effect of Pitavastatin Versus Atorvastatin in Patients With Hypercholesterolemia and Mild to Moderate Hepatic Damage.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms PITCH
- Sponsors JW Pharmaceutical
- 30 Mar 2012 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
- 30 Mar 2012 Company (JW Pharmaceutical) added, actual initiation date (Jun 2009) added and additional lead trial investigator (Kyoo-Rok Han) identified as reported by ClinicalTrials.gov.
- 02 Aug 2010 New trial record